Research Article

[Retracted] Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study

Table 3

Comparison of marker conversion [].

Group 2a ()Group 2b ()

HBV-DNA negative conversion rate
 T18 (19.05)13 (30.95)1.5870.208
 T224 (57.14)25 (59.52)0.0490.825
 T334 (80.95)36 (85.71)0.3430.558
HBsAg negative conversion rate
 T11 (2.38)2 (4.76)0.3460.557
 T23 (7.14)4 (9.52)0.1560.693
 T35 (11.90)5 (11.90)
HBeAg negative conversion rate
 T18 (19.05)10 (23.81)0.2830.595
 T214 (33.33)15 (35.71)0.0530.819
 T322 (52.38)24 (57.14)0.1920.661